Dragomabin
Dragomabin is a lipopeptide isolated from the marine cyanobacteria Lyngbya majuscula. It has in vitro antimalarial activity. In 2018, a laboratory synthesis of dragomabin was reported. The synthesis identified a misassignment of the configuration of the stereogenic center on the alkyne-bearing fragment and it was revised from to.